Aventis Enoxaparin Sodium Manufacturing Plant, Singapore
The Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999. Aventis commissioned the plant to...
The Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999. Aventis commissioned the plant to...
Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013. The research facility is...
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity....
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics....
Halaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai...
Phase Holographic Imaging (PHI) today announces a collaboration agreement with Northeastern University of Boston. PHI will provide Northeastern with HoloMonitor®...
Mylan Inc. (MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3...
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility...
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive...
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.